🇺🇸 FDA
Patent

US 7405314

Compounds and methods for the treatment of cancer

granted A61PA61P1/04A61P1/16

Quick answer

US patent 7405314 (Compounds and methods for the treatment of cancer) held by The Board of Regents of the University of Texas System expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
45
CPC classes
A61P, A61P1/04, A61P1/16, A61P1/18, A61P11/00